Berlin, Germany

Tilo Haag


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tilo Haag: Innovator in Pharmaceutical Chemistry

Introduction

Tilo Haag is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative treatments for inflammation-related diseases. With a total of 2 patents, Haag's work has the potential to impact the medical community significantly.

Latest Patents

Haag's latest patents focus on the crystalline potassium salt of a lipoxin A analog. This invention includes processes for preparing these crystalline potassium salts, methods for using them to treat disease states characterized by inflammation, and pharmaceutical compositions that comprise such crystalline potassium salts. His work in this area demonstrates a commitment to advancing therapeutic options for patients suffering from inflammatory conditions.

Career Highlights

Throughout his career, Tilo Haag has worked with prominent companies in the pharmaceutical industry, including Bayer Schering Pharma AG and Bayer Pharma Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of pharmaceutical science.

Collaborations

Haag has collaborated with several professionals in his field, including Danja Grossbach and Gabriele Winter. These partnerships have likely enriched his research and development efforts, fostering an environment of innovation and creativity.

Conclusion

Tilo Haag's contributions to pharmaceutical chemistry, particularly through his patents related to lipoxin A analogs, highlight his role as an influential inventor. His work continues to pave the way for new treatments in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…